DHR

Danaher Corporation

Healthcare Diagnostics & Research NYSE

About the company

The journey of Danaher traces back to the year 1984 when a group of visionary leaders made the bold decision to reshape a real estate organization into a dynamic and thriving industrial manufacturing company. This transformative step marked the beginning of Danaher Corporation's incredible legacy in the world of manufacturing. Driven by a relentless pursuit of innovation, Danaher embarked on a journey of growth through a series of strategic mergers, acquisitions, and divestitures. These moves allowed the company to expand its expertise and product offerings, establishing itself as a leader in manufacturing scientific instruments and consumables. Today, Danaher's operations are organized into three key segments: life sciences, diagnostics, and environmental and applied solutions. Each segment focuses on providing cutting-edge solutions tailored to specific industry needs. The life sciences segment encompasses a range of scientific instruments and consumables that play a vital role in research and development, pharmaceutical manufacturing, and biotechnology. Through advancements in technologies and an unwavering commitment to excellence, Danaher empowers researchers, scientists, and healthcare professionals to make groundbreaking discoveries and enhance patient care. In the diagnostics segment, Danaher offers innovative solutions to enable accurate and efficient diagnosis of diseases. With a comprehensive portfolio of diagnostic instruments, assays, and reagents, the company plays a crucial role in precision medicine, enabling healthcare providers to deliver personalized treatments and improve patient outcomes. The environmental and applied solutions group, the third segment of Danaher's operations, focuses on delivering sustainable solutions to various industries. From water quality analysis to product identification and label printing, this segment helps companies navigate environmental challenges while optimizing their operational efficiency. However, in a strategic move to further align its portfolio and sharpen its focus on life sciences and diagnostics, Danaher announced in late 2022 its plans to divest its environmental and applied solutions group in 2023. This decision reflects the company's commitment to creating value for its customers and shareholders by concentrating its efforts on its core areas of expertise. By aligning its resources and expertise in life sciences and diagnostics, Danaher aims to enhance its ability to address the evolving needs of the scientific and healthcare communities. The divestiture will enable the company to invest more intensely in research and development, bringing forth innovative solutions that improve the quality of life globally. Danaher's dedication to operational excellence, customer-centricity, and strong collaboration have been instrumental in its success. With a global presence and a reputation for delivering high-quality products and services, the company continues to redefine what is possible in the field of scientific and healthcare manufacturing. As Danaher looks to the future, the company remains committed to driving positive change through its contributions to life sciences and diagnostics. With a renewed focus on its core segments, Danaher is poised to embark on a new chapter of innovation, further solidifying its position as a global leader in the manufacturing industry.

Website: https://www.danaher.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric DHR Sector median Vs. industry
P/E 34.86 20.10 ↑ Above average
EPS 5.16 USD -1.14 USD ↑ Above average
Dividend yield 0.74% 0.00% ↑ Above average
Profit margin 14.89% 0.00% ↑ Above average
ROE 7.08% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Danaher Corporation?
The journey of Danaher traces back to the year 1984 when a group of visionary leaders made the bold decision to reshape a real estate organization into a dynamic and thriving industrial manufacturing company. This transformative step marked the beginning of Danaher Corporation's incredible legacy in the world of manufacturing. Driven by a relentless pursuit of innovation, Danaher embarked on a journey of growth through a series of strategic mergers, acquisitions, and divestitures. These moves allowed the company to expand its expertise and product offerings, establishing itself as a leader in manufacturing scientific instruments and consumables. Today, Danaher's operations are organized into three key segments: life sciences, diagnostics, and environmental and applied solutions. Each segment focuses on providing cutting-edge solutions tailored to specific industry needs. The life sciences segment encompasses a range of scientific instruments and consumables that play a vital role in research and development, pharmaceutical manufacturing, and biotechnology. Through advancements in technologies and an unwavering commitment to excellence, Danaher empowers researchers, scientists, and healthcare professionals to make groundbreaking discoveries and enhance patient care. In the diagnostics segment, Danaher offers innovative solutions to enable accurate and efficient diagnosis of diseases. With a comprehensive portfolio of diagnostic instruments, assays, and reagents, the company plays a crucial role in precision medicine, enabling healthcare providers to deliver personalized treatments and improve patient outcomes. The environmental and applied solutions group, the third segment of Danaher's operations, focuses on delivering sustainable solutions to various industries. From water quality analysis to product identification and label printing, this segment helps companies navigate environmental challenges while optimizing their operational efficiency. However, in a strategic move to further align its portfolio and sharpen its focus on life sciences and diagnostics, Danaher announced in late 2022 its plans to divest its environmental and applied solutions group in 2023. This decision reflects the company's commitment to creating value for its customers and shareholders by concentrating its efforts on its core areas of expertise. By aligning its resources and expertise in life sciences and diagnostics, Danaher aims to enhance its ability to address the evolving needs of the scientific and healthcare communities. The divestiture will enable the company to invest more intensely in research and development, bringing forth innovative solutions that improve the quality of life globally. Danaher's dedication to operational excellence, customer-centricity, and strong collaboration have been instrumental in its success. With a global presence and a reputation for delivering high-quality products and services, the company continues to redefine what is possible in the field of scientific and healthcare manufacturing. As Danaher looks to the future, the company remains committed to driving positive change through its contributions to life sciences and diagnostics. With a renewed focus on its core segments, Danaher is poised to embark on a new chapter of innovation, further solidifying its position as a global leader in the manufacturing industry.
Are Danaher Corporation shares expensive?
The price-to-earnings (P/E) ratio of Danaher Corporation is 34.86 — the share price is 34.86 times the annual profit per share. That is higher than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is Danaher Corporation?
The market capitalization of Danaher Corporation — the combined value of all its shares — is 127.31 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Danaher Corporation pay dividends?
The dividend yield of Danaher Corporation is 0.74% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Danaher Corporation belong to?
Danaher Corporation operates in the Healthcare sector, industry: Diagnostics & Research.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120